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Abstract
Background: Alterations in the number and composition of lymphocytes and their subsets in blood are considered
a hallmark of immune system aging. However, it is unknown whether the rates of change of lymphocytes are
stable or change with age, or whether the inter-individual variations of lymphocyte composition are stable over
time or undergo different rates of change at different ages. Here, we report a longitudinal analysis of T- and B-cells
and their subsets, and NK cells in the blood of 165 subjects aged from 24 to 90 years, with each subject assessed at
baseline and an average of 5.6 years follow-up.
Results: The rates of change of T-(CD4+ and CD8+) and B-cells, and NK cells were relative stable throughout the
adult life. A great degree of individual variations in numbers of lymphocytes and their subsets and in the rates of
their changes with age was observed. Among them, CD4+ T cells exhibited the highest degree of individual
variation followed by NK cells, CD8+ T cells, and B cells. Different types of lymphocytes had distinct trends in their
rates of change which did not appear to be influenced by CMV infection. Finally, the rates of CD4+, CD8+ T cells,
naive CD4+ and naïve CD8+ T cells were closely positively correlated.
Conclusion: Our findings provide evidence that the age-associated changes in circulating lymphocytes were at
relative stable rates in vivo in a highly individualized manner and the levels of selected cytokines/cytokine receptors
in serum might influence these age-associated changes of lymphocytes in circulation.
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Background
Decline in immune function with age is viewed as a fun-
damental problem for the increased risk of age-
associated diseases or disabilities [1–3]. One of the hall-
mark changes in the immune system with age is the al-
teration of the number and composition of different
types of lymphocytes in the circulation. In older individ-
uals, the numbers of CD4+ and CD8+ T cells and B cells
are reduced whereas the numbers of NK cells are in-
creased as compared to younger individuals [4, 5]. At
the subset level, decreases of naïve T and B cells and in-
creases of memory T and B cells also occurs with aging
[6–11]. Such changes may reflect a combination of re-
duced production of naïve lymphocytes and the accumu-
lation of memory lymphocytes as the results of the
reduced overall production of lymphocytes and of the
host-environment interaction over time. Despite the
overall trend of age-associated changes, striking varia-
tions in the numbers of lymphocytes exist between indi-
viduals. It is currently unknown whether the observed
variations are due to stable characteristics that are main-
tained over time or whether different subjects have dif-
ferent rates of change with aging.
In the T cell compartment, age associated reduction of
CD4+ and CD8+ T cells as a percentage of peripheral
blood mononuclear cells (PBMCs) as well as absolute
numbers (cell/μl) in blood have been reported [5, 12,
13]. Within the T cell subsets, in addition to reduced
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naïve and increased memory CD4+ and CD8+ T cells
with age, studies have shown that CD4+ regulatory T
cells and CD8+CD28- T cells increase with age [14–16].
Thymic involution is the single most critical contributor
of reduction in naïve T cells with age [17] whereas cu-
mulative encounters with antigens over time is the force
driving the increase memory T cells [18], CD8+CD28- T
cells [16], as well as Tregs [19]. A similar decrease of
naïve and increase of memory B cells also occurs in the
B cell compartment but the magnitude of change is not
as profound as what is observed in T cells [6, 20]. Interest-
ingly, natural killer cells (NK cells) are the only lymphoid
linage cells that increase with aging [4, 21, 22]. However,
the cytotoxic activity of NK cells appears to be reduced
with age and thus the increase in NK cell number may be
interpreted as compensatory. Some of the alterations in
lymphocyte composition are considered biomarkers of
immunosenenscence (ratio of CD4/CD8, increase of
CD28- T cells, and increase of NK cells) because they are
associated with mortality in elderly [23, 24].
Information regarding age-related changes in lympho-
cyte composition in humans is mostly derived from
cross-sectional studies. This approach may be biased by
selective mortality or participation attrition and, in
addition, lack the time dimension necessary to dissect
cross-sectional and longitudinal effects. Data from longi-
tudinal studies should allow for the determination of
whether changes in lymphocyte compositions occur at a
constant rate or are non-linear over time and whether
there are detectable causes of these changes.
Here, we conducted a longitudinal analysis of CD4+
and CD8+ T cells, B cells and their subsets, and NK cells
in 165 participants from the Baltimore Longitudinal
Study of Aging (BLSA) (https://www.blsa.nih.gov/) assessed
at baseline and, on average, after a 5-year follow-up. We
analyzed the rates of changes and explored potential causes
of variations and correlation among these changes and with
CMV infection. Our findings provide detailed longitudinal
rates of changes in lymphocytes and their subsets with
aging in a relatively healthy population dispersed over a
relatively wide age-range.
Methods
Study design and participants
We performed a longitudinal study of T- and B-cells and
their subsets, and NK cells in peripheral blood of 165
BLSA participants at first visit and 5-year follow-up
under the NIH IRB- approved protocol (GRC98-12-28-
01) and performed in accordance with the Declaration
of Helsinki. Demographic characterization of these par-
ticipants was summarized in Additional file 1: Table S1.
At each visit, blood cell counts were measured by stand-
ard complete blood cell counts by Coulter Counter and
PBMCs were isolated from 50 mL blood drawn from
participants under fasting condition and cryopreserved
in liquid nitrogen. Two to five cryopreserved PBMCs
from each subject with an average of 5.6 years apart
were used in the experiments. PBMCs from all time
points were thawed and counted on the day of the experi-
ment. The recovery of frozen PBMC was 77 % ± 0.3 %
(mean ± SEM). Complete blood cell counts was combined
with flow cytometry analysis (see gating strategy in Add-
itional file 1: Figure S1) to obtain the cell count and to es-
timate rate changes for different cell populations.
Analysis by flow cytometry
Antibodies used for flow cytometry analysis included:
CD2-Tri-Color (TC); CD4-Phycoerythrin (PE) and CD4Al-
lophycocyanin (APC); CD28-Fluorescein Isothiocyanate
(FITC); CD8-TC; CD19-APC; CD45RA-APC; CD16-FITC
from Life Technologies (Grand Island, NY); CD14-PE;
CD27-PE; and IgM-FITC from BD Biosciences (San Jose,
CA). Freshly thawed PBMCs from each visit were stained
with three to five antibodies: T cells (CD2, CD4, CD8,
CD45RA, and CD28); B cells (CD19, IgM, and CD27); NK
cells (CD16). The data were collected on a BD FACSCali-
bur or BD FACSCanto II, and analyzed by Cell-Quest (BD
Biosciences) and FlowJo. The gating strategies were pre-
sented in Additional file 1: Figure S1.
Measurement of selected biomarkers and CMV IgG
Fasting blood was collected at each visit for measurement
of complete blood cell count and other routine blood
chemistry using the standard method under the BLSA
protocol. Sera were isolated from blood and stored in a
-80 °C freezer prior to cytokine (IL) measurement using a
custom-made multiplex assay (BioRad Luminex Assays)
according to the manufacturer’s instruction. CMV IgG
was measured from sera of 120 subjects (117 of them had
two time points and 3 had single time points) using the
ELISA kit (Abcam, # ab108639) according to the manu-
facturer’s instruction.
Statistical analysis
Figures were plotted as scatterplots with a linear regres-
sion line. The regression lines for rate and percentage
rate of change by age were analyzed using linear regres-
sion. Regressions of number of cells and percent of cells
were tested using mixed effects linear regression on age
with a random effect for subject to address the within-
subject correlation with the repeated measurements. The
inclusion of the time difference between the measure-
ments did not affect the assessment. For the regression
models, all tests were performed with a p < 0.05. Correla-
tions were calculated between pairs of variables, and after
adjusting by FDR [25], p value less or equal to 0.005 is
considered as significant. To address the question
whether rapid rates of change are present across more
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cell types than expected, rates for each cell type were di-
chotomized and summed to identify subjects in the tertile
with the greatest rate of cell loss (except for NK rates
which were the highest tertile). The summed score was
compared to the expected binomial distribution by chi-
squared test. Assuming a binomial distribution, the prob-
ability coefficient was estimated from the data using the
Bayesian modeling program rstan (http://mc-stan.org/
rstan.html). A single sample proportion test was used to
test whether the proportion of subject with summed
score of 4 or more was greater in the data as compared
to the expected summed score of 4 or more from a bino-
mial distribution with probability of 0.33.
All statistical analyses were done using R version
2.12.1 (http://www.r-project.org).
Results
Changes of CD4+ T cells and their subsets in peripheral
blood with age in vivo
In agreement with previous reports, at baseline older age
was associated with slightly lower number of CD4+ T
(Additional file 1: Figure S2a) [26, 27]. Rates of change
of CD4+ T cell, reported as cell number per μl blood per
year, were quite heterogeneous across study subjects
(ranging from -120 to +170 cells/μl/yr and an average of
9.8 cells/μl/yr) and were relatively stable at different ages
(Fig. 1a). Next, we examined rates of change in three sub-
sets of CD4+ T cells, including naïve (CD45RA+CD28+),
Treg (CD25+Foxp3+), and CD28- cells. Similar to previous
reports, older age was associated with fewer naïve CD4+ T
cells (Additional file 1: Figure S2b) [28, 29]. Similarly to
the total CD4+ T cells, there were remarkable individual
variability in rates of change in naïve CD4+ T cells (ran-
ging from -80 to +108 cells/μl/yr and average 4.3 cells/μl/
yr) but the average trend of change with age was surpris-
ingly flat, suggesting that naïve phenotype CD4+ T cells
were well maintained throughout the adult life span in the
absence of apparent new genesis from the thymus (Fig. 1b).
In agreement with previous reports [14, 30], Treg (CD4
+CD25+FOXP3+) tended to be more numerous in older
than in younger individuals (Additional file 1: Figure S2c).
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Fig. 1 Rate of CD4+ T cells and subsets change with age in vivo. a Rate of CD4+ T cells in peripheral blood in number of cells per μl blood. The
rate of CD4+ T cells was calculated based on flow cytometry analysis using the gating strategy described in (Additional file 1: Figure S1) and
lymphocyte counts from complete blood counts. The linear regressions rate over time are -0.26 cell/μl/year (N = 165). b Rate of naïve CD4+ T cells
in CD4+ T cells in number of cells per μl blood. The rate of naïve CD4+ T cell in cell/μl/year was based on flow cytometry analysis and
lymphocyte counts from complete blood counts (N = 158). c Rate of regulatory CD4 T (Treg) cells in peripheral blood (N = 112). Treg was defined
by expression of CD25 and Foxp3. d Rate of CD4+CD28- T cells in peripheral blood (N = 160). P values were calculated by linear regression in this
and subsequent figures
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of change in Treg (ranging from -4 to +10 cells/μl/yr
and average 1.4 cells/μl/yr) was smaller than that of
naïve cells but similarly stable in the trend of change
with age (Fig. 1c). We observed a similar age-related in-
crease of CD4+CD28- T cells from ages 20 to 90 (Add-
itional file 1: Figure S2d). Again, the rate of change in
CD4+CD28- T cells showed individual variations and
the trend of rate of change with age was relatively stable
(ranging from -23 to +60 cells/μl/yr and average 1.6
cells/μl/yr) (Fig. 1d). Together, these results showed a
great degree of individual variation in the rates of change
in CD4+ T cells and their subsets among study subjects.
Overall there was a rather stable trend in the rates of
changes in CD4+ T cells and their subsets over the adult
life time.
Changes in CD8+ T cells and their subsets in peripheral
blood with age in vivo
In CD8+ T cells, we observed a similar age related reduc-
tion in the number of cells/μl blood in our study cohort of
cross-sectional analysis as previously reported [31–33]
(Additional file 1: Figure S3a). The rate of change in CD8+
T cells (ranging from -163 to +69 cells/μl/yr and average
-1.3 cells/μl/yr) showed a comparable degree of variation
as observed in CD4+ T cells and the overall rate of change
of CD8+ T cells was remarkably stable throughout the
adult lifetime (Fig. 2a). Decrease of naïve CD8+ T cells in
blood with age was observed in this study cohort
(Additional file 1: Figure S3b) as well as in previous re-
ports [5, 12, 13]. The rates of naïve CD8+ T cells (ranging
from -34 to +43 cells/μl/yr and average -1.8 cells/μl/yr)
also displayed a high degree of individual variations with
no significant change of the average rates at different ages
(Fig. 2b). The increase of CD8+CD28- T cells with age is
considered as a signature of T cell aging and was ob-
served in this study (Additional file 1: Figure S3c). Inter-
estingly, while the rates of change with age of CD8
+CD28- T cells showed individual variations (ranging
from -121 to +53 cells/μl/yr and average 0.9 cells/μl/yr),
the average trend was not significantly changed with
age, suggesting that the increase of CD8+CD28- T cells
was accumulated through a relatively constant rate over
the adult lifetime (Fig. 2c). Collectively, the individual
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Fig. 2 Rate of CD8+ T cells and subsets change with age in vivo. a Rate of CD8+ T cells in peripheral blood in number of cells per μl blood (N = 162).
The rate of CD8+ T cells was calculated based on flow cytometry analysis using the gating strategy described in (Additional file 1: Figure S1) and
lymphocyte counts from complete blood counts. b Rate of naïve CD8+ T cells in CD8+ T cell in cell number per μl blood (N = 159). Naïve CD8+ T cell
were defined by CD45RA+/CD28+. c Rate of CD8+CD28- T cells in CD8+ T cell in cell number per μl blood (N = 162). d Ratio of CD4+/CD8+ T cells
(number of cells/μl) as a function of age (N = 162). P values were calculated by linear regression in this and subsequent figures
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their subsets were similar to those of CD4+ T cells; the
overall trend of the rates of CD8+ T cells and their
subsets were largely stable over the adult life. Previ-
ous studies suggest that a reduction of the CD4/CD8
ratio with increasing age is an “Immune Risk Profile
(IRP)” [23, 24, 34, 35]. Here, we evaluated whether
the CD4+/CD8+ ratio reduced with age along with the
number of cells in the blood, and found that the
average ratios of CD4/CD8 T cells were relatively
stable with age (mean ± SD = 3.4 ± 2.5) (Fig. 2d). Thus,
a reduction in CD4+/CD8+ ratio was not observed as
a general trend of age in this study cohort.
Changes in B cells and their subsets in peripheral blood
with age in vivo
B cells were defined based by the expression of CD19
and naïve and memory B cells were defined based by
CD19+IgM+CD27- and CD19+CD27+, respectively
(Additional file 1: Figure S1). We observed a reduc-
tion of total B cells as well as naïve B cells with age in
our study cohort from the cross-sectional analysis
(Additional file 1: Figure S4a-b), and a slight increase
in memory B cells with age (Additional file 1: Figure
S4c). The average rate of change in B cells was -6.6
cells/μl/yr, and the trend of the rate did not differ
across the adult age span (Fig. 3a). Similarly, the aver-
age rate of change in naïve B cells was -5.5 cells/μl/yr,
and the trend of the rate across the adult age span
was flat (Fig. 3b). The average rate of change of mem-
ory B cells was -0.1 cells/μl/yr across the age span
(Fig. 3c). Overall, these findings showed that the aver-
age loss of B cells and naïve B cells with age in vivo
did not alter with the subject’s age.
Change of NK cell and its subsets in peripheral blood
with age in vivo
Increase of NK cells in peripheral blood with aging has
been reported [4, 21, 36] and was also observed in this
study (Additional file 1: Figure S5). Here, we analyzed the
major population of NK cells defined by CD14-CD16+
(Additional file 1: Figure S1), which is composed of
around 90 % of NK cells (Le Garff-Tavernier et al., 2011).
The rate of change in NK cells displayed wide individual
variation among the study subjects (from -180 to 100
cells/μl/yr) (Fig. 4). Among the average rates of T (CD4
and CD8) and B cells, the average rate of NK cells of all
subjects was the highest (25.3 cells/μl/yr) with no change
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Fig. 3 Rate of B cells and subsets change with age in vivo. a Rate of B cells in peripheral blood in cell number per μl blood. The rate of B cell
was calculated based on flow cytometry analysis using the gating strategy described in (Additional file 1: Figure S1) and lymphocyte counts from
complete blood (N = 162). b Rate of naïve B cells in B cell in cell number per μl blood (N = 218). Naïve B cells were defined by CD19+IgM+CD27-.
c Rate of memory B cells in B cell in cell number per μl blood (N = 162). Memory B cells were defined by CD19+CD27+
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Correlation between changes among different types of
lymphocytes and selected cytokines and soluble cytokine
receptors, and antibodies against cytomegalovirus (CMV)
in blood
To determine whether the rates of change in subsets of
lymphocytes correlated with each other and with some
physiological measurements such as levels of cytokines
and soluble cytokine receptors in blood and other
physiological parameters, we compared the rate of
change of each type of lymphocyte subset with the per-
cents and counts of lymphocytes and a panel of cyto-
kines and physiological parameters (Additional file 1:
Table S2) using Pearson’s partial correlation coefficient
adjusted for age (Fig. 5). Lymphocyte count was posi-
tively correlated with body fat and LDL in sera (Fig. 5).
The rate of change in CD4+ T cells showed a positive
correlation with the rates of change for naïve CD4+ and
naïve CD8+ T cells, total CD8+ T cells, CD4+CD28- cells
and CD8+CD28- cells, but a negative correlation with
numbers of CD4+ cells and naïve CD4+ cells (Fig. 5).
The rate of naïve CD4+ T cells was positively corre-
lated with the rates of change of CD4+, CD8+ and naïve
CD8+ T cells but negatively correlated with numbers of
CD4+ and naïve CD4+, and naïve CD8+ T cells (Fig. 5).
The rate of Treg cells was positively correlated with
numbers of CD4+ and naïve CD4+ T cells, and rate of
CD4+CD28- cells (Fig. 5). To determine whether there is
a tendency for subjects who show rapid rates of change
in one cell type to show similar changes in other cell
types, we dichotomized the rates for each cell type to
identify subjects in the tertile with the greatest rate of
cell loss (except for NK rates which were the highest ter-
tile) and the seven dichotomized rates were summed
(total score 0 to 7). If the cell rates are independent, the
distribution should be binomial with probability 0.33,
which was not the case by chi-squared test (p < 0.0001).
The probability which fits the summed score was 0.38
that is significantly different that the 0.33 used in creat-
ing the score (p < 0.02). If the cell rates occur together,
the expectation would be for an excessive proportion of
subjects to have high summed scores. The expected
probability of a score of 4 or more is 0.17, while the ob-
served proportion is 0.23 (p = 0.03). The high proportion
of high counts argues that there is evidence that rapid
rates tend to co-occur among cell types far more often
than would be expected by chance (i.e. being independ-
ent). Finally, the rate of CD4+CD28- cells was positively
correlated with the rates of CD4+, Treg and CD8+CD28-
T cells (Fig. 5).
The rate of CD8+ T cells showed a positive correlation
with the rates of CD8+CD28-, naïve CD8+, total CD4+,
naïve CD4+ T cells and serum level of IL-15 and a nega-
tive correlation with number of CD8+ T cells, CD8
+CD28- T cells, and rate of naïve B cells (Fig. 5). The rate
of change of naïve CD8+ T cells was positively correlated
with rates of change of CD4+, CD8+, and naïve CD4+ T
cells but negatively correlated with the numbers of naïve
CD8+ T cells (Fig. 5). Finally, the rate of change of CD8
+CD28- T cells was positively correlated with the rates of
CD8+, CD4+, CD4+CD28- and serum level of IL-15 but
negatively corrected with numbers of CD8+ CD8+CD28-
T cells, and rate of naïve B cells (Fig. 5). The ratio of
CD4+/CD8+ T cell number was positively correlated
with numbers of CD4+, Treg, and naïve CD4+ but
negatively numbers of CD8+, CD8+CD28-, and naïve
CD8 T cells, and CMV seropositivity defined by the
presence of anti-CMV IgG antibodies in sera (Fig. 5).
The association CMV seropositivity with the low ratio
of CD4+/CD8+ found here is in agreement with the
previous report [37].
The rate of B cells was positively correlated with
serum levels of soluble TNFRI and TNFRII, and rates of
naïve and memory B cells but was negatively correlated
with the numbers of B cells and naïve B cells (Fig. 5).
The rate of naïve B cells was positively correlated with
rate of B cells but negatively correlated with numbers of
naïve B, naïve B cells, rates of CD8+CD28- and CD8+ T
cells (Fig. 5). The rate of change of memory B cells was
positively correlated with serum levels of soluble TNFRI
and numbers of NK cells (Fig. 5). Finally, the rate of
change of NK cells was negatively correlated with the
serum level of triglyceride (Fig. 5).
Discussion
Limited information is available regarding the trajector-
ies of in vivo aging of immune cells in humans. As
lymphocyte numbers in peripheral blood exhibit a great
degree of individual variation, it is unclear whether
inter-individuals differences are due to individual’s char-
acteristics that remain stable with aging or result from
























Fig. 4 Rate of NK cells changes with age in vivo. The rate of NK cells
was calculated based on flow cytometry analysis using the gating
strategy described in (Additional file 1: Figure S1) and lymphocyte
counts from complete blood counts (N = 162)
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Fig. 5 Correlation of rate changes and cytokines/soluble receptor levels in sera. a Correlation coefficient among the rate changes of lymphocytes
and selected cytokines/their receptors. The correlation coefficients between pair comparison were analyzed with adjustment for age, and presented as
a clustered heat map. # refers to the cell counts (x103/μl) and R# refers to the rate of changes used cell counts (cell counts/year). b Significant
correlations were presented with correlation coefficient (R) and p values. After adjusting by FDR, p value is significant less or equal to 0.005
Lin et al. Immunity & Ageing  (2016) 13:24 Page 7 of 10
lymphocytes in across individuals. Our longitudinal ana-
lysis showed that the rates of changes of all four major
types of lymphocytes (CD4+, CD8+, B, and NK cells)
were also highly individualized. The average rates of
change of all four major types of lymphocytes were quite
stable in the study subjects across 70 years of adult life.
It will be necessary to further examine these changes in
a longer time follow-up such as 10 or 20 years to under-
stand the contributing genetic and environmental factors
that determine the individual variation. Such a study will
require long-term commitment and resources but the
yield will have the details and resolution needed to bet-
ter understand these age-associated changes within the
immune system.
One of the most prominent signs of an immune sys-
tem aging is a significant reduction of naïve lymphocytes
in blood. The reduction of naïve lymphocytes occurs
continuously with advancing age, which has been mainly
attributed to a reduction of thymic output after puberty
and imperfect peripheral maintenance. However, it is
unknown whether the loss of naïve lymphocytes occurs
at a constant or increasing rate with age. Our longitu-
dinal analysis showed that the trends of rates of change
of naïve CD4+ and CD8+ T cell and naïve B cells over
70 years of adult life were remarkably flat, indicating that
the continuous reduction of naïve T and B cells in blood
is due to a cumulative effect during aging. This conclu-
sion is further supported by study using 2H2O labeling
showed similar dynamics of lymphocytes between young
and elderly subjects [38]. In contrast to naïve lympho-
cytes, CD28- T cells (both CD4+ and CD8+) and NK cells
increase in blood with age. Interestingly, we observed
that the trends of the rates of change of CD4+CD28- T
cells and NK cells (Figs. 1c and 4a) but not CD8+CD28-
T cells (Fig. 2c) also slightly increase with age. This sug-
gests that age-associated increase of CD4+CD28- T cells
and NK cells with age is not only accumulated over time
but also increased in pace with age.
A reduced CD4+/CD8+ ratio is considered as one of
the immune risk phenotypes (IRP) related to increased
morbidity and mortality in elderly [23, 24, 34, 35]. In
agreement with previous finding [37], we also found that
the ratio of CD4/CD8 T cells is negatively correlated
with CMV seropositivity and the trend of the CD4+/CD8
+ ratio was not substantially changed with age (Fig. 2e).
Collectively, these findings suggest that a reduction in
the CD4+/CD8+ ratio is not a general change with age in
this study cohort but is more obvious to the CMV in-
fected old subjects.
Correlational analysis of the rates of change of lym-
phocytes and their subsets with some selected cytokines
and soluble cytokine receptors revealed some unex-
pected findings. We found that the rates of CD8+ and
CD8+ CD28-T cells were positively correlated with levels
of serum IL-15. In contrast to T cells, rates of B cells
and memory B cells were positively correlated with sol-
uble TNF-RI. IL-15 is a critical growth factor for CD8+
T cells [39] and TNF alpha can induce B cell prolifera-
tion [40], their positive correlations suggest that cytokine
mediated peripheral expansion is an influencing factor
of the rate of changes.
We have applied 11 cell lineage/differentiation
makers in analyzing 4 major lymphocyte populations in
blood. Although using frozen PBMCs in this study pre-
vents selection of those temperature sensitive markers
such as CD62L and CCR7, there are more differenti-
ation markers that can be used to improve the reso-
lution and precision of age-associated changes in these
lymphocyte subsets. In particular, applying IgD and IgG
staining could further separate naïve and memory B cell
subpopulations as some of those subpopulations display
more obvious age-related changes [41–43]. Therefore,
further study is warranted to precisely assess the age-
associated change of lymphocyte composition and func-
tion in vivo.
Conclusion
In conclusion, our findings showed that the rates of
changes in T (CD4+ and CD8+), B, NK cells and their
subsets are highly individualized, exhibiting a wide range
regardless of the subject’s age and the average trends of
the rates of changes were relatively flat over 70 years of
adult life. Unexpectedly, we observed significant associ-
ations of the serum levels of certain cytokines and cyto-
kine receptors with the rates of change in selected
lymphocytes and their subjects. Collectively, our find-
ings provide much needed information of the in vivo
changes of lymphocyte compositions and numbers in
blood with age, the interrelationship among different
type of lymphocytes and their subsets, and potential
contributions of serum cytokines/cytokine receptors in
these age-associated changes. Future study with a longer
time span, samples with multiple time points and as-
sessment with more differentiation markers will further
enhance our understanding of how and when the alter-
ations of lymphocyte type, composition, and number
occur, and will be essential to better guide clinical inter-
ventions such as vaccination with improved precision
and efficacy in the elderly.
Additional file
Additional file 1: Figure S1. The gating strategy for CD4+, CD8+ T cells,
B cells and NK cells, and their subsets. Figure S2. The population change
of CD4+ T cells with age. Figure S3. The population change of CD8+ T
cells with age. Figure S4. The population change of B cells with age.
Figure S5. The population change of NK cells with age. Table S1.
Demographics of the study subjects at the first evaluation. Table S2.
Measures of selected biomarkers. (DOCX 6035 kb)
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